|
Name |
1,2,4,5-Tetramethylbenzene
|
Molecular Formula | C10H14 | |
IUPAC Name* |
1,2,4,5-tetramethylbenzene
|
|
SMILES |
CC1=CC(=C(C=C1C)C)C
|
|
InChI |
InChI=1S/C10H14/c1-7-5-9(3)10(4)6-8(7)2/h5-6H,1-4H3
|
|
InChIKey |
SQNZJJAZBFDUTD-UHFFFAOYSA-N
|
|
Synonyms |
1,2,4,5-TETRAMETHYLBENZENE; 95-93-2; Durene; Durol; Benzene, 1,2,4,5-tetramethyl-; p-Xylene, 2,5-dimethyl-; 1,2,4,5-tetramethyl-benzene; CHEBI:38978; 181426CFYB; NSC-6770; DSSTox_CID_9124; DSSTox_RID_78675; DSSTox_GSID_29124; CAS-95-93-2; NSC 6770; EINECS 202-465-7; Duren; UNII-181426CFYB; AI3-25182; CCRIS 8660; 2,5-dimethyl-p-xylene; DURENE [MI]; NCIMech_000514; BIDD:ER0685; 1,2,4,5-tetramethyl benzene; CHEMBL1797134; DTXSID1029124; NSC6770; WLN: 1R B1 D1 E1; ZINC1295393; Tox21_201920; Tox21_303511; 1,2,4,5-TETRAMETHLYBENZENE; MFCD00008528; STL268879; 1,2,4,5-Tetramethylbenzene, 98%; AKOS000119934; NCGC00249135-01; NCGC00257264-01; NCGC00259469-01; LS-13806; DB-038211; FT-0625629; T0140; T0714; 1,2,4,5-TETRAMETHYLBENZENE (DURENE); EN300-19396; Q907919; W-100151; F0001-2285; Z104473710; 1,2,4,5-Tetramethylbenzene, Standard for quantitative NMR, TraceCERT(R)
|
|
CAS | 95-93-2 | |
PubChem CID | 7269 | |
ChEMBL ID | CHEMBL1797134 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 134.22 | ALogp: | 4.0 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.507 |
Caco-2 Permeability: | -4.631 | MDCK Permeability: | 0.00001950 |
Pgp-inhibitor: | 0.079 | Pgp-substrate: | 0.02 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.962 |
30% Bioavailability (F30%): | 0.968 |
Blood-Brain-Barrier Penetration (BBB): | 0.899 | Plasma Protein Binding (PPB): | 92.28% |
Volume Distribution (VD): | 0.914 | Fu: | 6.03% |
CYP1A2-inhibitor: | 0.762 | CYP1A2-substrate: | 0.948 |
CYP2C19-inhibitor: | 0.603 | CYP2C19-substrate: | 0.898 |
CYP2C9-inhibitor: | 0.13 | CYP2C9-substrate: | 0.717 |
CYP2D6-inhibitor: | 0.302 | CYP2D6-substrate: | 0.933 |
CYP3A4-inhibitor: | 0.11 | CYP3A4-substrate: | 0.523 |
Clearance (CL): | 9.843 | Half-life (T1/2): | 0.429 |
hERG Blockers: | 0.019 | Human Hepatotoxicity (H-HT): | 0.076 |
Drug-inuced Liver Injury (DILI): | 0.068 | AMES Toxicity: | 0.221 |
Rat Oral Acute Toxicity: | 0.023 | Maximum Recommended Daily Dose: | 0.619 |
Skin Sensitization: | 0.249 | Carcinogencity: | 0.656 |
Eye Corrosion: | 0.961 | Eye Irritation: | 0.996 |
Respiratory Toxicity: | 0.036 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001026 | 0.447 | D0Y4DY | 0.271 | ||||
ENC000342 | 0.444 | D0FA2O | 0.259 | ||||
ENC000180 | 0.429 | D0X0RI | 0.245 | ||||
ENC000728 | 0.385 | D01PJR | 0.235 | ||||
ENC000084 | 0.368 | D06GIP | 0.222 | ||||
ENC000614 | 0.351 | D0X4RN | 0.220 | ||||
ENC000364 | 0.351 | D0U3DU | 0.214 | ||||
ENC000242 | 0.351 | D05VIX | 0.213 | ||||
ENC002336 | 0.317 | D0S5CH | 0.203 | ||||
ENC005230 | 0.317 | D09EBS | 0.203 |